Clinical Trial Update: Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of HS-10365 in patients with advanced solid tumors is reported as an early clinical trial update with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• HS-10365

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN